ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.384,09
-0,56%
S&P 500
5.352,96
-0,15%
Dow Jones
38.674,56
-0,50%
Euro vs US Dollar
1,07234
-0,37%
Bitcoin
66.819,99
-3,87%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. NeuroMetrix Inc (NURO)

  7. NeuroMetrix Inc (NURO) News

NURO

NeuroMetrix (NURO)

NeuroMetrix Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NURO
DatumZeitQuelleÜberschriftSymbolFirma
31/05/202419h15Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:NURONeuroMetrix Inc
24/05/202423h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
24/05/202423h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
24/05/202423h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
15/05/202422h00GlobeNewswire Inc.NeuroMetrix Reports Q1 2024 Business HighlightsNASDAQ:NURONeuroMetrix Inc
15/05/202418h33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NURONeuroMetrix Inc
15/05/202417h19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NURONeuroMetrix Inc
07/05/202422h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
19/04/202414h00GlobeNewswire Inc.NeuroMetrix Announces Steps Taken to Enhance Shareholder ValueNASDAQ:NURONeuroMetrix Inc
14/03/202414h00GlobeNewswire Inc.NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral NeuropathyNASDAQ:NURONeuroMetrix Inc
13/03/202414h00GlobeNewswire Inc.NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® FibromyalgiaNASDAQ:NURONeuroMetrix Inc
06/03/202423h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
06/03/202423h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
06/03/202423h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
06/03/202423h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
04/03/202422h12Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NURONeuroMetrix Inc
01/03/202423h07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NURONeuroMetrix Inc
27/02/202422h45Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NURONeuroMetrix Inc
27/02/202422h00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:NURONeuroMetrix Inc
26/02/202423h41Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:NURONeuroMetrix Inc
22/02/202413h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NURONeuroMetrix Inc
22/02/202413h00GlobeNewswire Inc.NeuroMetrix Reports Q4 and Full Year 2023 Business HighlightsNASDAQ:NURONeuroMetrix Inc
20/02/202420h49Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NURONeuroMetrix Inc
15/02/202415h00GlobeNewswire Inc.NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference CallNASDAQ:NURONeuroMetrix Inc
13/02/202415h00GlobeNewswire Inc.NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder ValueNASDAQ:NURONeuroMetrix Inc
12/12/202315h00GlobeNewswire Inc.NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)NASDAQ:NURONeuroMetrix Inc
05/12/202315h00GlobeNewswire Inc.NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell® Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN)NASDAQ:NURONeuroMetrix Inc
20/11/202315h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NURONeuroMetrix Inc
20/11/202315h00GlobeNewswire Inc.NeuroMetrix Announces One-for-Eight Reverse Stock SplitNASDAQ:NURONeuroMetrix Inc
26/10/202322h20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NURONeuroMetrix Inc
 Showing the most relevant articles for your search:NASDAQ:NURO

Kürzlich von Ihnen besucht

BIT
F22160
Vontobel Financial Produ...
BIT
PRY
Prysmian
XE
TM5
T Mobile USA
BIT
S27466
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten